# Suramin in Treating Patients With Recurrent Primary Brain Tumors

> **NCT00002639** · PHASE2 · COMPLETED · sponsor: **Emory University**

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** chemotherapy
- **DRUG:** suramin

## Key facts

- **NCT ID:** NCT00002639
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-07
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002639, "Suramin in Treating Patients With Recurrent Primary Brain Tumors". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00002639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*